Benchmarking schizophrenia with a focus on pharmacotherapy and metabolic syndrome

被引：0

作者：

Prescott, J. ^{[1
]}

机构：

[1] MCM Grp, Marlton, NJ USA

来源：

关键词：

D O I：

10.1016/S1098-3015(10)70352-1

中图分类号：

F [经济];

学科分类号：

02 ;

摘要：

引用

页码：A109 / A109

页数：1

共 50 条

[31] Pharmacotherapy of idiopathic Parkinson's syndrome with special focus on neuroprotection
Reichmann, H
Summer, U
Gerlach, M
Riederer, P
NERVENHEILKUNDE, 2001, 20 (04) : 227 - +
[32] Should the Metabolic Syndrome Patient with Prediabetes Be Offered Pharmacotherapy?
Sullivan, Shannon D.
Ratner, Robert E.
CURRENT DIABETES REPORTS, 2011, 11 (02) : 91 - 98
[33] Pharmacotherapy for schizophrenia
Fleischhacker, W. W.
Hummer, M.
NERVENARZT, 2006, 77 : S77 - S97
[34] PHARMACOTHERAPY OF SCHIZOPHRENIA
GOLDSTEIN, JM
LANCET, 1995, 346 (8972): : 450 - 450
[35] PHARMACOTHERAPY OF SCHIZOPHRENIA
GOLD, DD
HOSPITAL FORMULARY, 1984, 19 (02): : 153 - &
[36] Pharmacotherapy of schizophrenia
Correll, C. U.
NERVENARZT, 2020, 91 (01): : 34 - 42
[37] PHARMACOTHERAPY OF SCHIZOPHRENIA
KLERMAN, GL
ANNUAL REVIEW OF MEDICINE, 1974, 25 : 199 - 217
[38] PHARMACOTHERAPY OF SCHIZOPHRENIA
REMINGTON, G
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 1989, 34 (03): : 211 - 220
[39] Should the Metabolic Syndrome Patient with Prediabetes Be Offered Pharmacotherapy?
Shannon D. Sullivan
Robert E. Ratner
Current Diabetes Reports, 2011, 11 : 91 - 98
[40] PHARMACOTHERAPY OF OBESITY IN PATIENTS WITH KNEE OSTEOARTHRITIS AND METABOLIC SYNDROME
Strebkova, E.
Alekseeva, L.
ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1132 - 1133